[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]CAO W,CHEN HD,YU YW,et al.Changing profiles of cancer burden worldwide and in China:A secondary analysis of the global cancer statistics 2020[J].Chin Med J(Engl),2021,134(7):783-791.
[3]孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤,2019,28(1):1-11.
SUN KX,ZHENG RS,ZHANG SW,et al.Report of cancer incidence and mortality in different areas of China,2015[J].China Cancer,2019,28(1):1-11.
[4]MACHLOWSKA J,BAJ J,SITARZ M,et al.Gastric cancer:Epidemiology,risk factors,classification,genomic characteristics and treatment strategies[J].Int J Mol Sci,2020,21(11):4012.
[5]CAO G,LI HB,YIN Z,et al.Recent advances in dynamic m6A RNA modification[J].Open Biol,2016,6(4):160003.
[6]MEYER KD,JAFFREY SR.Rethinking m6A readers,writers,and erasers[J].Annu Rev Cell Dev Biol,2017,33:319-342.
[7]WANG Y,LU JH,WU QN,et al.LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer[J].Mol Cancer,2019,18(1):174.
[8]XU X,YU Y,ZONG K,et al.Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway[J].J Exp Clin Cancer Res,2019,38(1):497.
[9]HAWKINS SFC,GUEST PC.Multiplex single nucleotide polymorphism analyses[J].Methods Mol Biol,2017,1546:143-148.
[10]MOCELLIN S,TROPEA S,BENNA C,et al.Circadian pathway genetic variation and cancer risk:Evidence from genome-wide association studies[J].BMC Med,2018,16(1):20.
[11]JI X,YAN Y,MA N,et al.Variant of SNPs at lncRNA NEAT1 contributes to gastric cancer susceptibility in Chinese Han population[J].Int J Clin Oncol,2021,26(4):694-700.
[12]FAN P,ZHANG Z,LU L,et al.Association of single nucleotide polymorphisms(SNPs) with gastric cancer susceptibility and prognosis in population in Wuwei,Gansu,China[J].World J Surg Oncol,2022,20(1):194.
[13]LIU G,ZHU T,CUI Y,et al.Correlation between IGF2BP2 gene polymorphism and the risk of breast cancer in Chinese Han women[J].Biomed Pharmacother,2015,69:297-300.
[14]YUSEFI AR,BAGHERI LANKARANI K,BASTANI P,et al.Risk factors for gastric cancer:A systematic review[J].Asian Pac J Cancer Prev,2018,19(3):591-603.
[15]LIU D,XIA AD,WU LP,et al.IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway[J].Cell Signal,2022,94:110313.
[16]OUYANG J,LI J,LI D,et al.IGF2BP2 promotes epithelial to mesenchymal transition and metastasis through stabilizing HMGA1 mRNA in gastric cancer[J].Cancers(Basel),2022,14(21):5381.
[17]LIN HY,HUANG PY,CHENG CH,et al.KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness[J].Sci Rep,2021,11(1):9264.
[18]KATOH M,LGARASHI M,FUKUDA H,et al.Cancer genetics and genomics of human FOX family genes[J].Cancer Lett,2013,328(2):198-206.
[19]于丽娜,于景翠.单核苷酸多态性与中国人群胃癌易感性和进展相关性的研究现状[J].现代肿瘤医学,2020,28(10):1773-1777.
YU LN,YU JC.Research on the relationship between the single nucleotide polymorphism(SNP) and the gastric cancer susceptibility and its progression in Chinese population[J].Modern Oncology,2020,28(10):1773-1777.
[20]ALMAWI WY,ZIDI S,SGHAIER I,et al.Novel association of IGF2BP2 gene variants with altered risk of breast cancer and as potential molecular biomarker of triple negative breast cancer[J].Clin Breast Cancer,2023,23(3):272-280.
[21]CHOU CH,CHANG CY,LU HJ,et al.IGF2BP2 polymorphisms are associated with clinical characteristics and development of oral cancer[J].Int J Mol Sci,2020,21(16):5662.
[22]TANG W,CHEN S,LIU J,et al.Investigation of IGF1,IGF2BP2,and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk[J].J Cell Biochem,2019,120(4):5510-5518.
[23]CHEN S,QIU H,LIU C,et al.Relationship between IGF2BP2 and IGFBP3 polymorphisms and susceptibility to non-small-cell lung cancer:A case-control study in Eastern Chinese Han population[J].Cancer Manag Res,2018,10:2965-2975.
[24]WANG X,GUAN D,WANG D,et al.Genetic variants in m6A regulators are associated with gastric cancer risk[J].Arch Toxicol,2021,95(3):1081-1088.